Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]
Phase 3 trial evaluating safety and efficacy of Hectorol in pediatric CKD stage 3-4 with secondary hyperparathyroidism; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 study evaluating safety, efficacy, and pharmacokinetics of paricalcitol for pediatric secondary hyperparathyroidism in stage 5 chron…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up [NA]
This clinical trial update notes the completion of a study comparing surgery to follow-up for primary hyperparathyroidism in patients older …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 1]
This document reports the completion of a Phase 1 mass balance study of [14C] SHR6508 in Chinese hemodialysis patients with secondary hyperp…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 2]
Phase 2 clinical trial evaluating MT1013 for safety, tolerability, and efficacy in patients with secondary hyperparathyroidism due to chroni…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease [Phase 2]
Phase 2 trial of MT1013 Injection for secondary hyperparathyroidism in chronic kidney disease patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Upfront Ultrasound for Preoperative Localization in Primary Hyperparathyroidism
This trial evaluated upfront ultrasound localization to guide preoperative planning for parathyroid surgery in primary hyperparathyroidism a…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]
This completed clinical trial evaluates near-infrared autofluorescence for identifying parathyroid glands during parathyroidectomy, with res…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: The Trial of SHR6508 in Secondary Hyperparathyroidism [Phase 3]
A Phase 3 trial of SHR6508 for secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 clinical trial assessing safety, efficacy and pharmacokinetics of paricalcitol for secondary hyperparathyroidism in pediatric patien…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 [Phase 3]
A Phase 3 trial evaluating a parathyroid hormone attenuation therapy in patients undergoing hemodialysis with secondary hyperparathyroidism …
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 [Phase 3]
A Phase 3 trial evaluating a parathyroid hormone attenuation strategy in hemodialysis patients with secondary hyperparathyroidism and end-st…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]
The clinical trial evaluating near-infrared autofluorescence to identify parathyroid glands during parathyroidectomy has completed, and resu…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]
Phase 3 pediatric trial evaluating the safety and efficacy of Hectorol (doxercalciferol) for secondary hyperparathyroidism in children with …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism [Phase 3]
A Phase 3 trial of CTAP101 extended-release capsules in children with secondary hyperparathyroidism was terminated, and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
A non-interventional study evaluating the effectiveness of RAYALDEE (paricalcitol) in non-dialysis CKD patients with secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: F-18 PSMA for Localization of Parathyroid Adenoma
A clinical trial evaluating F-18 PSMA as a localization aid for parathyroid adenomas in hyperparathyroidism has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cinacalcet for treating hypercalcemia and secondary hyperparathyroidism in renal transplant recipients…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI [Phase 2]
Phase 2 trial evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of CTAP101 (calcifediol) ER capsules for secondary hype…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of LEO 27847 in patients with secondary hyperparathyroi…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Near Infrared Autofluorescence Imaging in Minimally-Invasive Video-Assisted Parathyroidectomy (NIRAF MIVAP Study)
Clinical trial update reporting completion of a study evaluating near infrared autofluorescence imaging during minimally invasive video-assi…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Abnormally High Parathyroid Hormone Levels Worsens Outcomes in Vitamin D Depleted Critical Care Patients
Clinical trial update (NCT06711874) indicates that abnormally high parathyroid hormone levels worsen outcomes in vitamin D-deficient critica…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis [Phase 2]
Phase 2 study evaluating ASP7991 in secondary hyperparathyroidism patients undergoing hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera [NA]
The completed study evaluated the validity of parathyroid exploration using a CZT camera in patients with primary hyperparathyroidism. This …
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: 18F-fluorocholine PET/CT for Hyperparathyroidism [NA]
A completed clinical trial evaluating 18F-fluorocholine PET/CT for imaging in hyperparathyroidism. Sponsor: Buddhist Tzu Chi General Hospita…